EEF1B2

Elongation factor 1-beta · P24534 · EEF1B2 on Sugi Atlas →

0 patent compounds predicted against EEF1B2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to EEF1B2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors PHASE1COMPLETED
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) nanRECRUITING
MEHMO Natural History and Biomarkers nanRECRUITING
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
Autophagy Bladder Cancer nanUNKNOWN
Precision Medicine in Anesthesia nanWITHDRAWN
ERA Test in Patients With Recurrent Implantation Failure nanUNKNOWN
TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH nanWITHDRAWN
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Research on the Early and Prognosis Diagnosis of Vascular Dementia nanRECRUITING
Longitudinal Biomarkers With Selected Outcome Measures In CMT nanRECRUITING
Recombinant Interferon Alfa-2b in Treating Patients With Melanoma nanCOMPLETED
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise nanCOMPLETED
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a EEF1B2 binder may also engage these)

ProteinNameSimilarity
Q5E983 1.000 Q5E983 →
P29412 1.000 P29412 →
Q9YGQ1 1.000 Q9YGQ1 →
O70251 1.000 O70251 →
P34826 1.000 P34826 →
Q6DET9 1.000 Q6DET9 →
A6IPG1 1.000 A6IPG1 →
P12262 1.000 P12262 →
P29545 1.000 P29545 →
P30151 1.000 P30151 →
O74173 0.998 O74173 →
Q40680 0.998 Q40680 →
P29522 0.997 P29522 →
P78590 0.996 P78590 →
P93447 0.996 P93447 →
P48006 0.995 P48006 →
Q9GRF8 0.995 Q9GRF8 →
P34460 0.995 P34460 →
Q69BZ7 0.995 Q69BZ7 →
P29546 0.995 P29546 →
Q9SCX3 0.993 Q9SCX3 →
P32471 0.993 P32471 →
Q9SI20 0.993 Q9SI20 →
Q40682 0.993 Q40682 →
O96827 0.992 O96827 →
O81918 0.990 O81918 →
P32192 0.989 P32192 →
Q84WM9 0.988 Q84WM9 →
P34827 0.986 P34827 →
Q69JW2 0.983 Q69JW2 →